![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharmaceuticals Begins Trading On OTC Bulletin Board Under Ticker Symbol SPHC
December 17, 2007 10:10 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 17, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharmaceuticals to Trade On OTC Bulletin Board
December 13, 2007 10:23 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 13, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) (https://www.samaritanpharma.com), announces that it is seeking to have its common stock trade under a new stock...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharma Retains The Investor Relations Group of New York
December 04, 2007 10:51 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 4, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Presents Favorable Caprospinol Data At Alzheimer's Drug Development Summit November 30
November 27, 2007 09:23 ET
|
Samaritan Pharmaceuticals, Inc.
Conference Showcases the Latest Disease Modifying Therapies and
Pre-Symptomatic Approaches for Alzheimer's Drug Development
Dr. Lecanu to Present Favorable Caprospinol Data Showing the Clearing
...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Announces Update on Pharmaplaz Funding
November 09, 2007 17:45 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 9, 2007 (PRIME NEWSWIRE) -- LAS VEGAS November 9, 2007--Samaritan Pharmaceuticals, Inc. (AMEX:LIV) announces that on October 16, 2007, Samaritan announced that it received $8.6 million...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Expands Revenue Opportunities With Marketing Authorization Approval for HIV Drug Amphocil in Cyprus
November 08, 2007 10:20 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) is pleased to announce that its subsidiary, Samaritan Pharmaceuticals Europe, S.A., has received notification...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors
November 06, 2007 10:38 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 6, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc., a developer of innovative drugs (AMEX:LIV), is honored to announce that Ms. Anna Strasberg has joined Samaritan's Advisory...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Receives $8.6 Million Upfront Payment Under Commercialization Agreement for HIV Drug
October 16, 2007 11:31 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today that, under a March 9, 2007 agreement with Pharmaplaz, Ltd., a...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
October 11, 2007 09:52 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 11, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life saving drugs announced today it has signed an exclusive licensing and...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Highlights Its Most Innovative HIV, Hepatitis C and Alzheimer's Drugs to Partner at Europe's Bio Partnering Conference
October 08, 2007 09:22 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today its CEO Dr. Janet Greeson will highlight drugs in Samaritan's...